Terry Wilcox

Co-Founder & Executive Director


A passionate advocate for patients with cancer and other serious diseases, Terry Wilcox is Executive Director of Patients Rising, a non-profit patient education and advocacy organization that helps patients get access to essential diagnostics and the treatments they need. Inspired by Selma Schimmel, considered by many as the “original” young adult survivor advocate, Terry left a career in Los Angeles in the entertainment industry to join Vital Options International (VOI), a cancer communication, education and advocacy organization Selma launched in 1983 to facilitate a global dialogue on cancer. From 2008 to Selma’s death in May 2014, Terry worked alongside her mentor as creative director of VOI and the supervising producer of a video program called The Group Room that featured discussions with the world’s leading oncologists and cancer researchers. After Selma’s death, Terry continued to advance Selma’s legacy as VOI’s ExecutiveDirector until August 2015, when she moved to Washington, DC and co-founded Patients Rising with her husband. Now Terry and her team engage the patient community, along with physicians, health policy experts and allied healthcare professions, to develop realistic, solution-oriented discussions so those with life-threatening and chronic diseases will have a voice in shaping policies that will improve access to quality care.

Paul Langley, B.Sc. (Econ), M.A., Ph.D.

Lead Researcher

Dr. Paul Langley is a professional economist. His undergraduate training was in the UK with postgraduate training in Canada. Dr Langley has taught in the UK (University of Lancaster) and in Australia (La Trobe University) with visiting appointments at Carleton University, the University of Ohio, and the University of California-Irvine.

Following his undergraduate and graduate studies, Dr. Langley served as an Associate Professor at the University of Arizona’s College of Pharmacy, and the University of Colorado’s School of Pharmacy. He later worked as the U.S. and International Manager of Health Economics at 3M Pharmaceuticals, with worldwide responsibilities for economic evaluations as they apply to drug development, reimbursement and post-market entry support. During his time at 3M, Dr. Langley was appointed Adjunct Professor in the graduate faculty of the College of Pharmacy, University of Minnesota, an appointment he still holds today. He also manages Maimon Research, LLC, a boutique consulting company that works in major disease areas as well as advising on document management and minimum evidentiary standards for drug development decisions and reimbursement. In over 30 commentaries published in the University of Minnesota journal INNOVATIONS in Pharmacy, Dr. Langley has provided critiques of the current standards of claims evaluation, in particular the construction of non-evaluable cost-per-QALY models.

Jim Sliney, Jr.

director of Patient content

As Director of Patient Content at Patients Rising, Jim works very closely with the people who have healthcare war stories to tell. As a Columbia University trained writing consultant Jim has worked closely with writers of all levels of skill to help them find and refine their voices. Jim is a writer, editor, author and medical assistant with over 20 years of experience in healthcare. He’s spent over two decades in clinical care and research at some of New York’s biggest health institutions doing hands-on nursing, education and advocacy for rare disease patients. He has worked with several non-profit patient support organizations doing outreach, advocacy and creating educational content. He lives in New York City with his wife and their cats…sooo many cats.

Joe Keenan

Digital Director

Joe directs the digital strategy, operations and marketing for Patients Rising.  He is responsible for developing and enhancing the organization’s digital assets, applications, and online content across its web properties, mobile, and social channels.  Joe has been working in healthcare marketing, communications and content development for 20 years, specifically in the areas of cancer, substance abuse, chronic illness, and patient advocacy.